Chaudhry A, Stone W J, Breyer J A
Division of Nephrology, Vanderbilt University Medical Center, Nashville, TN 37232-2372.
Am J Kidney Dis. 1993 Feb;21(2):180-3. doi: 10.1016/s0272-6386(12)81090-0.
Patients with end-stage renal disease on hemodialysis have documented defects in their immune responses, and infections contribute significantly to their morbidity and mortality. This study prospectively detected and quantitated leukocyturia and bacteriuria in asymptomatic hemodialysis patients. Thirty-one percent of asymptomatic hemodialysis patients had significant pyuria (> 10 white blood cells per high-power field) and 25% had bacteriuria of pathologic dimensions, (> 1 x 10(5)/mL of a single microorganism). Pyuria was a good marker for significant bacteriuria in these patients. These results demonstrate that the urinary tract, even in ESRD patients on hemodialysis, may represent a significant reservoir for infection.
接受血液透析的终末期肾病患者存在免疫反应缺陷的记录,感染对其发病率和死亡率有显著影响。本研究前瞻性地检测并定量了无症状血液透析患者的白细胞尿和菌尿。31%的无症状血液透析患者有显著脓尿(每高倍视野>10个白细胞),25%有病理意义的菌尿(单一微生物>1×10⁵/mL)。脓尿是这些患者显著菌尿的良好标志物。这些结果表明,即使在接受血液透析的终末期肾病患者中,尿路也可能是一个重要的感染源。